# Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females

> **NCT01422135** · PHASE1 · COMPLETED · sponsor: **Agile Therapeutics** · enrollment: 24 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** AG200-15

## Key facts

- **NCT ID:** NCT01422135
- **Lead sponsor:** Agile Therapeutics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2011-04
- **Final completion:** 2011-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-12-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01422135

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01422135, "Pharmacokinetic Study of AG200-15 Transdermal Patch to Three Anatomical Sites in Healthy Females". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01422135. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*